[SYRE] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -25.01%
YoY- -129.80%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 0 0 0 0 0 2,378 1,510 -
PBT -21,573 -18,019 -17,167 -14,898 -11,917 -9,414 -8,119 91.72%
Tax 0 0 0 0 0 0 0 -
NP -21,573 -18,019 -17,167 -14,898 -11,917 -9,414 -8,119 91.72%
Tax Rate - - - - - - - -
Total Cost 21,573 18,019 17,167 14,898 11,917 11,792 9,629 71.13%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -395.88 -537.68 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -16.40 -13.72 -14.79 0.00 -13.55 -11.43 -12.17 21.98%
EPS Diluted -16.40 -13.72 -14.79 0.00 -13.55 -11.43 -12.17 21.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.